Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Broader Use of Blood Biomarkers Key to Maximizing Leqembi’s Value: Eisai Exec
October 18, 2023
- IBM Leads Development of Integrated Drug Supply Database for Wholesaler Reps, Pharmacists
October 18, 2023
- Guardant Liquid Biopsy Test Approved as CDx for Targeted Colorectal Cancer Drugs
October 17, 2023
- Telomelysin-Radiation Combo Hits Mark in PII Esophageal Cancer Study: Oncolys
October 17, 2023
- Meiji/KM’s XBB.1.5-Tailored COVID Jab to Enter Pediatric PIII Study
October 17, 2023
- EU Panel Backs Astellas’ Hot Flash Drug
October 17, 2023
- Oral Flu Drug Prescriptions 17 Times Higher than Pre-COVID: September Survey
October 16, 2023
- Japan Pharma Market to Contract after 2027 on Biosimilar Influx: Fuji Keizai
October 13, 2023
- Shonan iPark Looks to Woo Korean Firms by Partnering with Govt: Chief
October 13, 2023
- Viatris to Discontinue 28 APIs/48 Products for Supply, Productivity Reasons
October 12, 2023
- Healios Grabs Worldwide Rights to Athersys’ Cell Therapy in ARDS
October 12, 2023
- Astellas, Shared Lab Operators Link Up on Life Science Ecosystem
October 12, 2023
- Donanemab’s Limited Duration of Dosing Benefits Patients on Safety Front: Lilly CSO
October 11, 2023
- Japan Ethical Drug Sales Surge 8.1% in August: Crecon
October 10, 2023
- Kyowa Kirin to Acquire Orchard to Forge Ahead in Gene Therapy
October 6, 2023
- Hyperhidrosis Drug Ecclock Filed in South Korea: Kaken
October 6, 2023
- Opdivo Snatches Back Top Spot in Japan Sales Ranking in September: Encise
October 6, 2023
- Sawai Bags CML Nod for Sprycel Generic
October 5, 2023
- JCR to Explore Best Opportunities for Overseas Alliance on JR-171: Exec
October 5, 2023
- Manlio Florenzano Takes Helm of Sandoz Japan as Spin-Off Completes
October 5, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…